![](/img/cover-not-exists.png)
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
Jimenez-Shahed, JoohiLanguage:
english
Journal:
Neuropsychiatric Disease and Treatment
DOI:
10.2147/NDT.S16085
Date:
December, 2011
File:
PDF, 314 KB
english, 2011